AKEBIA THERAPEUTICS, INC. Increase (Decrease) in Other Operating Assets
AKEBIA THERAPEUTICS, INC. (AKBA) reported Increase (Decrease) in Other Operating Assets of $976.00 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2016-03-14
- AKEBIA THERAPEUTICS, INC. increase (decrease) in other operating assets for fiscal 2015 was $976.00K, a 445.25% increase from fiscal 2014.
- AKEBIA THERAPEUTICS, INC. increase (decrease) in other operating assets for fiscal 2014 was $179.00K, a 43.20% increase from fiscal 2013.
- AKEBIA THERAPEUTICS, INC. increase (decrease) in other operating assets for fiscal 2013 was $125.00K.
| Period end | Increase (Decrease) in Other Operating Assets 12 month | Increase (Decrease) in Other Operating Assets 85 month |
|---|---|---|
| 2015-12-31 | $976.00K 10-K · filed 2016-03-14 | |
| 2014-12-31 | $179.00K 10-K · filed 2016-03-14 | |
| 2014-03-31 | $125.34K 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $125.00K 10-K · filed 2016-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |